Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy

Conditions:   Colon Adenoma;   Colon Carcinoma;   Lynch Syndrome;   MLH1 Gene Mutation;   MSH2 Gene Mutation Intervention:   Biological: Nivolumab Sponsors:   Joanne Jeter;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials